Nantahala Capital Management, LLC Concert Pharmaceuticals, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$4.34 - $5.84 $237,706 - $319,862
-54,771 Reduced 3.06%
1,732,388 $10.1 Million
Q3 2022

Nov 10, 2022
BUY
$4.27 - $7.2 $543,652 - $916,696
127,319 Added 7.67%
1,787,159 $12 Million
Q2 2022

Aug 15, 2022
BUY
$2.8 - $6.36 $4.65 Million - $10.6 Million
1,659,840 New
1,659,840 $6.99 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email